Works matching IS 15588211 AND DT 2013 AND VI 8 AND IP 1

Results: 11

Management of the New Patient with CML in Chronic Phase.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 37, doi. 10.1007/s11899-012-0151-0

By:

Marin, David

Publication type:

Article

What Do We Do with Chronic Lymphocytic Leukemia with 17p Deletion?

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 81, doi. 10.1007/s11899-012-0143-0

By:

Sellner, L.;
Denzinger, S.;
Dietrich, S.;
Glimm, H.;
Merkel, O.;
Dreger, P.;
Zenz, T.

Publication type:

Article

Role of Epigenetics in Chronic Myeloid Leukemia.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 28, doi. 10.1007/s11899-012-0152-z

By:

Machova Polakova, Katerina;
Koblihova, Jitka;
Stopka, Tomas

Publication type:

Article

Monoclonal B Cell Lymphocytosis-What Does It Really Mean?

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 52, doi. 10.1007/s11899-012-0144-z

By:

Rawstron, Andy

Publication type:

Article

Lenalidomide Alone and in Combination for Chronic Lymphocytic Leukemia.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 7, doi. 10.1007/s11899-012-0146-x

By:

Chen, Christine

Publication type:

Article

Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 43, doi. 10.1007/s11899-012-0149-7

By:

Pavlů, Jiří;
Apperley, Jane

Publication type:

Article

GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 22, doi. 10.1007/s11899-012-0142-1

By:

Macias-Perez, Ines;
Flinn, Ian

Publication type:

Article

Signal Transduction in the Chronic Leukemias: Implications for Targeted Therapies.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 71, doi. 10.1007/s11899-012-0150-1

By:

Ahmed, Wesam;
Van Etten, Richard

Publication type:

Article

CARs in Chronic Lymphocytic Leukemia - Ready to Drive.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 60, doi. 10.1007/s11899-012-0145-y

By:

Hosing, Chitra;
Kebriaei, Partow;
Wierda, William;
Jena, Bipulendu;
Cooper, Laurence;
Shpall, Elizabeth

Publication type:

Article

Ibrutinib (PCI-32765), the First BTK (Bruton's Tyrosine Kinase) Inhibitor in Clinical Trials.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 1, doi. 10.1007/s11899-012-0147-9

By:

Brown, Jennifer

Publication type:

Article

Targeting Chronic Myeloid Leukemia Stem Cells.

Published in:

Current Hematologic Malignancy Reports, 2013, v. 8, n. 1, p. 14, doi. 10.1007/s11899-012-0148-8

By:

Kinstrie, Ross;
Copland, Mhairi

Publication type:

Article